Fig. 5: Level of MAIT cells before therapy can predict initial response to therapy. | Nature Communications

Fig. 5: Level of MAIT cells before therapy can predict initial response to therapy.

From: Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy

Fig. 5

Analysis of the cohort patients with metastatic melanoma indicates that patients with MAIT cells >1.7% of CD3+CD8+ T lymphocytes showed a better response to therapy compared to those with MAIT < 1.7% (p = 0.0363, Log-rank Mantel-Cox test). N < 1.7% = 4; N > 1.7% = 8.

Back to article page